ETBR Antibodies

Santa Cruz Biotechnology delivers a wide array of ETBR monoclonal antibodies for advanced research in cell signaling and receptor biology. ETBR monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Endothelin B receptor (ETBR) plays a crucial role in mediating the effects of endothelins, which are potent vasoconstrictors involved in regulating vascular tone and blood pressure. ETBR is actively involved in various physiological processes, including neuronal signaling and cell proliferation, making it a significant target for understanding cardiovascular and neurological disorders. The study of ETBR has become increasingly important for developing therapeutic strategies aimed at modulating receptor activity in various diseases. Researchers worldwide rely on ETBR monoclonal antibodies to advance their understanding of receptor function and regulation. Current investigations focus on how ETBR influences cellular responses and signaling pathways in different tissue types. ETBR monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to scientific knowledge in cardiovascular and neurological research.